跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LifeSenze Hemovan Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
LifeSenze Hemovan Capsule
Approved
STANDARD
LifeSenze Hemovan Capsule
HL PHARMACEUTICALS SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
dd19a7abe9fdfcfb
Company
HL PHARMACEUTICALS SDN. BHD.
Type
Standard
Approval Details
Approval Id
dd19a7abe9fdfcfb
Drug Approval Npra Name
LifeSenze Hemovan Capsule
Product Name
LifeSenze Hemovan Capsule
Registration Number
MAL23046058NC
Holder Company Name
HL PHARMACEUTICALS SDN. BHD.
Holder Address
NO. 760 & 762 JALAN SENTUL 51000 KUALA LUMPUR MALAYSIA
Holder Phone
0340419182
Manufacturer Company Name
Esprit Care Sdn. Bhd.
Manufacturer Address
NO. 61, 65, 67 & 69, JALAN TPP 1/13 TAMAN PERINDUSTRIAN PUCHONG, BATU 12 47100 PUCHONG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL23046058NC
Version
1751614256
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
dd19a7abe9fdfcfb
Type
Standard
Source
Official Source
Back to NPRA Approvals